ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC

ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC was reported 29 times

ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOVIRUS TEST POSITIVE 1 0.0105
1 SERRATIA SEPSIS 1 0.0093
2 ADENOVIRUS REACTIVATION 1 0.0069
3 MECHANICAL VENTILATION COMPLICATION 1 0.0067
4 OVARIAN FAILURE 1 0.0019
5 NASAL SEPTUM PERFORATION 1 0.0015
6 SPUTUM ABNORMAL 1 0.0015
7 SERRATIA INFECTION 1 0.0013
8 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
9 CATHETER SITE DISCHARGE 1 0.0009
10 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
11 ADENOVIRUS INFECTION 2 0.0007
12 SKULL FRACTURE 1 0.0006
13 RHINOVIRUS INFECTION 2 0.0005
14 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
15 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
16 HAEMATOLOGICAL INFECTION 1 0.0004
17 BLOOD PHOSPHORUS INCREASED 1 0.0004
18 CEREBRAL HAEMATOMA 1 0.0003
19 WOUND COMPLICATION 1 0.0003
20 SCLERODERMA 1 0.0003
21 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
22 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
23 IMPLANT SITE PAIN 1 0.0002
24 ENTEROCOCCAL INFECTION 1 0.0002
25 ELECTROLYTE IMBALANCE 2 0.0002
26 HYPOMAGNESAEMIA 2 0.0001
27 GRAFT VERSUS HOST DISEASE 1 0.0001
28 CYTOMEGALOVIRUS INFECTION 2 0.0001
29 PSEUDOMONAS INFECTION 1 0.0001
30 PYELONEPHRITIS 1 0.0001
31 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
32 VIRAL INFECTION 2 0.0001
33 BLOOD UREA INCREASED 1 0.0001
34 ACUTE RESPIRATORY FAILURE 1 0.0001
35 PULMONARY HYPERTENSION 1 0.0000
36 SKIN DISORDER 1 0.0000
37 RENAL DISORDER 1 0.0000
38 BLOOD GLUCOSE DECREASED 1 0.0000
39 DISCOMFORT 1 0.0000
40 DEHYDRATION 2 0.0000
41 ACUTE KIDNEY INJURY 2 0.0000
42 URINARY TRACT INFECTION 2 0.0000
43 HAEMOGLOBIN DECREASED 1 0.0000
44 PLATELET COUNT DECREASED 1 0.0000
45 PYREXIA 3 0.0000
46 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
47 DIARRHOEA 3 0.0000
48 VOMITING 2 0.0000
49 WEIGHT DECREASED 1 0.0000
50 PNEUMONIA 1 0.0000
51 FALL 1 0.0000
52 ASTHENIA 1 0.0000
53 FATIGUE 1 0.0000